Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 May;13(5):1301–1306. doi: 10.1128/iai.13.5.1301-1306.1976

Enhancement activity of anti-mycobacterial sera in experimental Mycobacterium bovis (BCG) infection in mice.

A Forget, J C Benoit, R Turcotte, N Gusew-Chartrand
PMCID: PMC420756  PMID: 818022

Abstract

The passive transfer of rabbit anti-mycobacterial immunoglobulins was directed against either living or soluble extracts of Mycobacterium tuberculosis strain H37Rv, which promotes the multiplication of the BCG strain of M. tuberculosis in the spleen of mice infected with low doses of this latter strain. This enhancing effect was reduced significantly when antisera were absorbed with living BCG. Moreover, such treatment led to the removal of all hemagglutinating antibodies when antisera were tested against either BCG or H37Rv soluble extracts. Therefore, it is most probable that the enhancing effect is related to the presence of mycobacterial antibodies.

Full text

PDF
1301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENOIT J. C., PANISSET M. SURVIE ET MULTIPLICATION DU BCG ET DU BACILLE TUBERCULEUX CHEZ LA SOURIS. IV. SURVIE ET MULTIPLICATION DE SOUCHES-FILLES DE BCG EN FONCTION DU TEMPS ET DE LA DOSE. Acta Tuberc Pneumol Scand. 1963;43:125–136. [PubMed] [Google Scholar]
  2. BENOIT J. C., QUEVILLON M., PANISSET M. OBTENTION PAR FILTRATION DE BACILLES ISOL'ES, DE SUSPENSIONS CONTENANT DES AGR'EGATS BACILLAIRES. MISE AU POINT D'UNE M'ETHODE QUANTITATIVE. Rev Can Biol. 1963 Sep-Dec;22:437–445. [PubMed] [Google Scholar]
  3. Boulanger R. P., Portelance V. Preservation of mycobacterial suspensions at -55 degrees C. Can J Microbiol. 1975 May;21(5):694–702. doi: 10.1139/m75-100. [DOI] [PubMed] [Google Scholar]
  4. CROWLE A. J., HU C. C. INHIBITION OF THE DEVELOPMENT OF DELAYED HYPERSENSITIVITY BY TREATMENT WITH ANTISERUM. J Immunol. 1965 Apr;94:555–562. [PubMed] [Google Scholar]
  5. Collins F. M., Mackaness G. B. The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol. 1970 Sep;1(3):253–265. doi: 10.1016/0008-8749(70)90047-x. [DOI] [PubMed] [Google Scholar]
  6. Collins F. M., Miller T. E. Growth of a drug-resistant strain of Mycobacterium bovis (BCG) in normal and immunized mice. J Infect Dis. 1969 Nov;120(5):517–533. doi: 10.1093/infdis/120.5.517. [DOI] [PubMed] [Google Scholar]
  7. Collins F. M., Montalbine V. Relative immunogenicity of streptomycin-sensitive and -resistant strains of BCG. Infect Immun. 1973 Sep;8(3):381–387. doi: 10.1128/iai.8.3.381-387.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FREEDMAN S. O., TURCOTTE R., FISH A. J., SEHON A. H. The in vitro detection of "cell-fixed" hemagglutinating antibodies to tuberculin purified protein derivative (PPD) in humans. J Immunol. 1963 Jan;90:52–59. [PubMed] [Google Scholar]
  9. Forget A., Borduas A. G., Richer G., Frappier A. Rôle d'anticorps facilitants dans le développement d'une infection bactérienne à caractère chronique: la synovite staphylococcique exérimentale du poussin. Rev Eur Etud Clin Biol. 1970 Oct;15(8):895–899. [PubMed] [Google Scholar]
  10. Forget A., Meunier L., Borduas A. G. Enhancement activity of homologous anti-staphylococcal sera in experimental staphylococcal synovitis of chicks: a possible role of immune adherence antibodies. Infect Immun. 1974 Apr;9(4):641–644. doi: 10.1128/iai.9.4.641-644.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GIMPL F., WEISSFEILER J. Studies on the antigenic structure of mycobacteria with the gel diffision technique. Acta Microbiol Acad Sci Hung. 1962;9:175–181. [PubMed] [Google Scholar]
  12. JENSEN K. A., KIAER I., LUNDBERG L. STUDIES ON THE ANTIGENIC STRUCTURE OF MYCOBACTERIA. I. Acta Pathol Microbiol Scand. 1964;61:619–632. doi: 10.1111/apm.1964.61.4.619. [DOI] [PubMed] [Google Scholar]
  13. KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
  14. MACKANESS G. B., SMITH N., WELLS A. Q. The growth of intracellular tubercle bacilli in relation to their virulence. Am Rev Tuberc. 1954 Apr;69(4):479–494. doi: 10.1164/art.1954.69.4.479. [DOI] [PubMed] [Google Scholar]
  15. Mackaness G. B., Blanden R. V., Collins F. M. Host-parasite relations in mouse typhoid. J Exp Med. 1966 Oct 1;124(4):573–583. doi: 10.1084/jem.124.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mackaness G. B. The immunology of antituberculous immunity. Am Rev Respir Dis. 1968 Mar;97(3):337–344. doi: 10.1164/arrd.1968.97.3.337. [DOI] [PubMed] [Google Scholar]
  17. PANISSET M., BENOIT J. C. [Survival and multiplication of BCG and of tuberclebacilli in the mouse as a function of time. I. Study of a measurement method]. Ann Inst Pasteur (Paris) 1959 Oct;97:437–452. [PubMed] [Google Scholar]
  18. PIERCE C. H., DUBOS R. J., SCHAEFER W. B. Multiplication and survival of tubercle bacilli in the organs of mice. J Exp Med. 1953 Feb 1;97(2):189–206. doi: 10.1084/jem.97.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SEVER J. L., YOUMANS G. P. The enumeration of nonpathogenic viable tubercle bacilli from the organs of mice. Am Rev Tuberc. 1957 Feb;75(2):280–294. doi: 10.1164/artpd.1957.75.2.280. [DOI] [PubMed] [Google Scholar]
  20. Sher N. A., Chaparas S. D., Pearson J., Chirigos M. Virulence of six strains of Mycobacterium bovis (BCG) in mice. Infect Immun. 1973 Nov;8(5):736–742. doi: 10.1128/iai.8.5.736-742.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tuboly S. Studies on the antigenic structure of mycobacteria. I. Comparison of the antigenic structure of pathogenic and saprophytic mycobacteria. Acta Microbiol Acad Sci Hung. 1965;12(3):233–240. [PubMed] [Google Scholar]
  22. Turcotte R. Yield of non-dialyzable mycobacterial constituents during the growth cycle. Can J Microbiol. 1969 Jan;15(1):35–41. doi: 10.1139/m69-006. [DOI] [PubMed] [Google Scholar]
  23. UHR J. W., BAUMANN J. B. Antibody formation. I. The suppression of antibody formation by passively administered antibody. J Exp Med. 1961 May 1;113:935–957. doi: 10.1084/jem.113.5.935. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES